McKesson Corporation (MCK)

NYSE · Medical Distribution

877.32
+17.40 (+2.02%)
Updated Aug 18, 4:42 PM ET
AI Rating
Hold
Overall Score
61
Trend
72
Momentum
55
Risk
50

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

McKesson Corporation is trading at $877.32, up 2.02% on the session. The 50 day average sits at $813.12 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 55.5, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $810.88 with resistance near $907.00, so that band frames the current range. Average daily movement is roughly $27.08, or about 3.1% of the share price, which is what any stop placement has to allow for. The overall health score of 61 out of 100 combines a trend score of 72, momentum of 55 and a risk score of 50.

Technical indicators

RSI (14)
55.5
strong
MACD
17.639
bearish crossover
SMA 20
857.57
SMA 50
813.12
SMA 200
--
unknown
ATR (14)
27.08
avg daily range
Support
810.88
Resistance
907.00
Volume vs 20d
0.60x
below average
Volatility
37.3%
annualised
1 month
+3.29%
3 months
+16.30%

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.